OmniaBio
Harsimran Jeet Singh, EIT, currently serves as an Associate Scientist II at OmniaBio since April 2023. Previously, Harsimran worked at Resilience as a Specialist I in Manufacturing Science and Technology, where responsibilities included planning and implementing scale-up processes and selecting equipment and raw materials. Prior experience includes an Engineer role at Sanofi Pasteur, focusing on project documentation and quality assurance collaboration, and an Assistant Executive position at Ind-Swift Laboratories Ltd., where contributions included manufacturing process design for various molecules. Harsimran began a career with a summer internship at Ind-Swift Laboratories Ltd. Harsimran holds a Master of Engineering in Chemical Engineering with a focus on Process Control from the University of Alberta and a Bachelor of Engineering in Chemical Engineering from Dr. S.S.B. UICET, PU, Chandigarh.
This person is not in any teams
OmniaBio
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world.